(Q47954750)

7 February 2018

title

The long-term outcome of anti-Jo-1-positive inflammatory myopathies (English)

1 reference

7 February 2018

6

Gerda Leinsinger

1 reference

7 February 2018

author name string

Michael Späth

1

1 reference

7 February 2018

Mira Schröder

2

1 reference

7 February 2018

Beate Schlotter-Weigel

3

1 reference

7 February 2018

Maggie C Walter

4

1 reference

7 February 2018

Hubert Hautmann

5

1 reference

7 February 2018

Dieter Pongratz

7

1 reference

7 February 2018

Wolfgang Müller-Felber

8

1 reference

7 February 2018

publication date

1 July 2004

1 reference

7 February 2018

published in

Journal of Neurology

1 reference

7 February 2018

volume

251

1 reference

7 February 2018

issue

7

1 reference

7 February 2018

page(s)

859-864

1 reference

7 February 2018

https://scigraph.springernature.com/pub.10.1007/s00415-004-0449-5

exact match

0 references

cites work

Pulse intravenous cyclophosphamide treatment for steroid-resistant interstitial pneumonitis associated with polymyositis

1 reference

12 December 2020

Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy

1 reference

12 December 2020

Cyclosporine treatment of steroid resistant interstitial pneumonitis associated with dermatomyositis/polymyositis.

1 reference

12 December 2020

Cyclosporine treatment for polymyositis/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis?

1 reference

12 December 2020

Update on myositis-specific and myositis-associated autoantibodies

1 reference

12 December 2020

Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: An open study with 20 adult patients

1 reference

12 December 2020

Anti-Jo-1 antibodies: specific autoantibodies for polymyositis with interstitial pulmonary fibrosis. 2 case reports

1 reference

12 December 2020

Treatment of refractory myositis: a randomized crossover study of two new cytotoxic regimens

1 reference

12 December 2020

Short term effects of intravenous pulses of cyclophosphamide in the treatment of connective tissue disease crisis

1 reference

12 December 2020

Tacrolimus in refractory polymyositis with interstitial lung disease

1 reference

12 December 2020

Frequency of relapses in patients with polymyositis and dermatomyositis.

1 reference

12 December 2020

Interstitial lung disease in polymyositis and dermatomyositis

1 reference

12 December 2020

Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis

1 reference

12 December 2020

The Jo-1 antibody system in myositis: relationships to clinical features and HLA.

1 reference

12 December 2020

Adverse impact of interstitial pulmonary fibrosis on prognosis in polymyositis and dermatomyositis

1 reference

12 December 2020

Combined use of cyclosporine A and methotrexate in refractory polymyositis.

1 reference

12 December 2020

Methotrexate therapy in polymyositis

1 reference

12 December 2020

A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups

1 reference

12 December 2020

Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis

1 reference

12 December 2020

Multifactorial study of inflammatory myopathies. Report of 29 cases

1 reference

12 December 2020

Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes

1 reference

12 December 2020

The failure of intravenous cyclophosphamide therapy in refractory idiopathic inflammatory myopathy

1 reference

12 December 2020

A longitudinal study of functional disability in a national cohort of patients with polymyositis/dermatomyositis

1 reference

12 December 2020

Current approach to the treatment of polymyositis and dermatomyositis

1 reference

12 December 2020

10.1007/S00415-004-0449-5

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018